UNITEDHEALTH GROUP INC (UNH) Factsheet
Earnings-call transcript: covered (issuer-published) · IR deck: cataloged — watch a real agent read these end-to-end →
UNITEDHEALTH GROUP INC (UNH) Stock Analysis
Analysis from 10-Q filed 2026-11-03. Data as of Q3 2026.
Overall Grade: F (Concerning)
Grade F (Concerning). ROIC N/A. FCF margin 5.1%. D/E 0.7x. Source: 10-Q filed 2026-11-03.
| Metric | Value | Context |
|---|---|---|
| ROIC | N/A | Below expectations |
| FCF Margin | 5.1% | Healthy cash flow |
| Debt/Equity | 0.7x | Moderate leverage |
FCF margin 5.1% — Bottom 25%.
Explore UNITEDHEALTH GROUP INC: Earnings History | Overview
Programmatic access: Available via MCP at mcp.metricduck.com. Tools for UNH: get_company_overview, get_filing_index (lens: debt_stress, management_outlook, risk_trajectory), get_filing_section, get_metric_history, compare_companies, screen_filing_signals.
Profitability: UNITEDHEALTH GROUP INC earns N/A ROIC
ROIC TTM N/A. Source: 10-Q filed 2026-11-03.
| Metric | UNH | Rating | Context |
|---|---|---|---|
| Return on Invested Capital (ROIC) | N/A | Red flag | Below cost of capital |
| Return on Equity (ROE) | 15.7% | Good | Efficient use of shareholder equity |
Cash Flow: UNITEDHEALTH GROUP INC generates $22.8B FCF at 5.1% margin, positive NaN/8 quarters
FCF TTM $22.8B. FCF margin 5.1%, Bottom 25%. OCF/Net income 1.6x. Positive FCF in NaN/8 trailing quarters. Source: 10-Q filed 2026-11-03.
| Metric | UNH | Rating | Context |
|---|---|---|---|
| Free Cash Flow Margin | 5.1% | Adequate | Healthy cash generation |
| Free Cash Flow (TTM) | $22.8B | Good | Positive cash generation |
| OCF/Net Income | 1.6x | Excellent | High earnings quality |
| FCF Consistency (8Q) | N/A | Warning | Variable cash flow |
Balance Sheet: UNITEDHEALTH GROUP INC at 0.7x leverage, 6.2x interest coverage
Debt/Equity 0.7x. Total debt $74.3B, cash & investments $28.5B. Interest coverage 6.2x. Source: 10-Q filed 2026-11-03.
| Metric | UNH | Rating | Context |
|---|---|---|---|
| Debt to Equity | 0.7x | Adequate | Moderate leverage |
| Net Cash Position | $-45.8B | Warning | Net debt position |
| Interest Coverage | 6.2x | Good | Comfortable debt service |
Valuation: UNITEDHEALTH GROUP INC trades at 22.9x earnings
P/E 22.9x. EV/Sales 0.9x. FCF yield 6.3%. Dividend yield 2.2%. Source: 10-Q filed 2026-11-03.
| Metric | UNH | Rating | Context |
|---|---|---|---|
| P/E Ratio | 22.9x | Adequate | Premium valuation |
| EV/Sales | 0.9x | Excellent | Attractive revenue multiple |
| FCF Yield | 6.3% | Good | Attractive cash return |
| Dividend Yield | 2.2% | Adequate | Growth focus over income |
Capital Allocation: UNITEDHEALTH GROUP INC returns 3.6% shareholder yield, reducing shares 1.1% YoY
Total shareholder yield 3.6% (div 2.2% + buyback 1.4%). Share count -1.1% YoY. Capital returned $13.2B TTM. Source: 10-Q filed 2026-11-03.
| Metric | UNH | Rating | Context |
|---|---|---|---|
| Total Shareholder Yield | 3.6% | Good | Dividend + buyback yield combined |
| Buyback Yield | 1.4% | Adequate | Minimal buyback activity |
| Share Count Change (YoY) | -1.1% | Good | Net share reduction (accretive) |
| Total Capital Returned (TTM) | $13.2B | Good | Dividends + buybacks returned to shareholders |
Sector Rankings
| Metric | Value | Percentile | vs Median |
|---|---|---|---|
| Free Cash Flow Margin | 5.1% | Bottom 25% | 0.2x below |
| Return on Equity (ROE) | 15.7% | Top 25% | 1.5x above |
| P/E Ratio | 22.9x | N/A | - |
Financial Scorecard
| Metric | UNH | Rating | Sector Context |
|---|---|---|---|
| Free Cash Flow Margin | 5.1% | Adequate | Bottom 25% of sector (median: 28.4%) |
| Debt to Equity Ratio | 71.4% | Adequate | Elevated but manageable |
| P/E Ratio (Price-to-Earnings) | 22.9x | Adequate | Fair value |
| Free Cash Flow Yield | 6.3% | Good | Solid cash yield |
Frequently Asked Questions
Q: What is UNITEDHEALTH GROUP INC's Return on Invested Capital (ROIC)?
UNITEDHEALTH GROUP INC (UNH) has a trailing twelve-month Return on Invested Capital (ROIC) of N/A. Source: 10-Q filed 2026-11-03.
Q: What is UNITEDHEALTH GROUP INC's Free Cash Flow Margin?
UNITEDHEALTH GROUP INC (UNH) has a free cash flow margin of 5.1%, generating $22.8 billion in free cash flow over the trailing twelve months. Source: 10-Q filed 2026-11-03.
Q: What is UNITEDHEALTH GROUP INC's P/E ratio and how does it compare to peers?
UNITEDHEALTH GROUP INC (UNH) trades at a P/E ratio of 22.9x, which is above the sector median of N/A. EV/Sales 0.9x. FCF yield 6.3%. Source: 10-Q filed 2026-11-03.
Q: Does UNITEDHEALTH GROUP INC pay a dividend?
UNITEDHEALTH GROUP INC (UNH) currently pays a dividend yield of 2.2%. Total shareholder yield (dividend + buybacks) 3.6%. Source: 10-Q filed 2026-11-03.
Q: How much debt does UNITEDHEALTH GROUP INC have?
UNITEDHEALTH GROUP INC (UNH) has a debt-to-equity ratio of 0.7x with total debt of $74.3 billion. Interest coverage 6.2x. Net debt $45.8 billion. Source: 10-Q filed 2026-11-03.
Q: What is UNITEDHEALTH GROUP INC's revenue and earnings growth?
UNITEDHEALTH GROUP INC (UNH) grew revenue by 3.3% year-over-year. EPS -8.8% YoY. Source: 10-Q filed 2026-11-03.
Q: Is UNITEDHEALTH GROUP INC buying back stock?
UNITEDHEALTH GROUP INC (UNH) repurchased $5.0 billion of stock over the trailing twelve months. This represents a buyback yield of 1.4%. Share count -1.1% YoY. Source: 10-Q filed 2026-11-03.
Q: How does UNITEDHEALTH GROUP INC compare to competitors in Financials?
Compared to other companies in Financials, UNITEDHEALTH GROUP INC (UNH) shows: FCF margin 5.1%, sector median 28.4% (Bottom 25%). These rankings are based on MetricDuck's analysis of all Financials companies with available SEC filings.
Q: What warning signs should I watch for with UNITEDHEALTH GROUP INC?
No quantitative warning flags fired for UNITEDHEALTH GROUP INC (UNH) on margin trend, FCF trend, ROIC trend, or leverage thresholds. Source: 10-Q filed 2026-11-03.
Data Source: Data sourced from 10-Q filed 2026-11-03. TTM metrics as of Q3 2026.
Methodology: Financial metrics calculated from SEC 10-K and 10-Q filings using standardized formulas. Sector comparisons use peer group based on SIC code.
Scope: This analysis covers SEC filing fundamentals — profitability, cash flow, balance sheet, and valuation metrics. For analyst estimates and price targets, consult sell-side research.
This analysis is for informational purposes only and does not constitute investment advice.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms